Nodal Modulator Regulates Chemo- and Radioresistance in Lung Cancer <i>via</i> the Chk2 Pathway
NOMO and the Chk2 pathway are involved in chemo- and radioresistance in lung cancer, highlighting NOMO as a potential target for the development of gene therapies for the treatment of patients with lung cancer.
Authors
- Jie Song (ORCID: https://orcid.org/0000-0002-5769-3886)
- Jeong‐Hwa Baek (ORCID: https://orcid.org/0000-0002-2032-1683)
- Jiyeon Ahn (ORCID: https://orcid.org/0000-0002-4098-7634)
- Jong Kuk Park (ORCID: https://orcid.org/0000-0001-5135-0033)
- Sang‐Gu Hwang (ORCID: https://orcid.org/0000-0002-3402-3708)
- Seung Jin Han (ORCID: https://orcid.org/0000-0003-4783-6799)
- Chang Geun Lee (ORCID: https://orcid.org/0000-0002-0256-1376)
- Ju‐Young Kim (ORCID: https://orcid.org/0000-0002-4493-0264)
- Hye Min Kim (ORCID: https://orcid.org/0000-0002-2899-9480)
- Chang‐Woo Lee (ORCID: https://orcid.org/0000-0001-9862-2833)
Institutions
- Inje University (KR)
- Korea Institute of Radiological and Medical Sciences (KR)
- Dongnam Institute of Radiological & Medical Sciences (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-10-28
- DOI
- https://doi.org/10.21873/anticanres.17830
- Primary Topic
- Effects of Radiation Exposure
- Type
- article
- Field-Weighted Citation Impact
- 0.00